Subscribe to Newsletter

Translational Science

Business & Regulation Standards & Regulation

FDA to Phase Out Animal Testing

| Rob Coker | 2 min read

FDA to phase out mandatory animal testing with human-relevant methods for drug development

Discovery & Development Drug Discovery

The Shingles Vaccine and Dementia

| Stephanie Vine | 2 min read

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Discovery & Development Drug Discovery

Hail to the Hardy Tardigrade

| Rob Coker | 2 min read

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3

| Stephanie Vine | 6 min read

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1

| Stephanie Vine | 6 min read

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

Discovery & Development Translational Science

Of Mice and Monkeys

| Rob Coker | 3 min read

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Business & Regulation Profession

Video Interview: Debra Weiss

Check out our video interview with Debra Weiss from the Bill & Melinda Gates Medical Research Institute.

Business & Regulation Trends & Forecasts

Dystopia or Utopia? Contribute to our Special Feature on the Future of Pharma

| Stephanie Vine | 4 min read

Contribute to our special feature celebrating the future of pharma.

Discovery & Development Formulation

MR Control

| Asma Patel, John McDermott | 4 min read

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

Manufacture Small Molecules

Food For Thought (and Sustainability)

| 5 min read

Biological engineering project featuring GSK seeks to use food by-products to create antimicrobials.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register